Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,624 signal articles · 79 in last 24h · 155,614 total before filter · latest 1h ago
79last 24h
847last 7d
141● bullish (7d)
90● bearish (7d)
214publishers
AllMacro195Earnings105M&A123Regulatory20Product21Analyst19
Sentiment:bullishneutralbearishshow all (incl. clickbait)
U.S. Stocks Fall as Iran War Inflation Heats Up
The Wall Street Journal25d agobearish
U.S. Stocks Fall as Iran War Inflation Heats Up

FINANCE U.S. stocks fell as renewed hostilities between the U.S. and Iran near the Strait of Hormuz caused oil prices and long-term Treasury yields to rise. The Dow Jones Industrial Average fell 374.

Apple Says OpenAI Is Destroying Evidence in Trade Secrets Case
Bloomberg25d agoneutral
Apple Says OpenAI Is Destroying Evidence in Trade Secrets Case

Apple Inc. escalated its legal battle against OpenAI, claiming in a new court filing that OpenAI is actively destroying crucial evidence and that former iPhone engineer Chang Liu “not only downloaded a confidential Apple circuit schematic but also used it in his work” at the AI company.

Stocks Decline to End August as War Fears Persist
The Wall Street Journal25d agoneutral
Stocks Decline to End August as War Fears Persist

Stocks fell and oil prices climbed Monday, with renewed fighting in the Middle East stoking unease on Wall Street. West Texas Intermediate crude futures, the U.S. benchmark for oil, rose 2.8% to $85.76 a barrel, after U.S. forces attacked two Iranian rocket launchers in the Strait of Hormuz Sunday, dampening hopes after weeks without American strikes that the war with Iran could soon draw to an end. Oil prices have swung wildly throughout August, with new developments leaving investors unsure about the possibility of a diplomatic resolution with Iran.

Barrick (B) Stock Could Be 11% Undervalued On IPO Update
Simply Wall St.25d agoneutral
Barrick (B) Stock Could Be 11% Undervalued On IPO Update

Barrick Mining has delivered a very strong 201.5% return over the past 3 years, while current valuation checks point to the stock trading below several intrinsic and market based estimates. For investors trying to make sense of the recent run, the question is how much of that strength is already reflected in today’s US$45.65 share price. A 201.5% gain over 3 years puts Barrick Mining among the stronger performers in its sector. This can raise the bar for what counts as good value from...

Amazon Shares Slip as FTC Lawsuit Looms
The Wall Street Journal25d agobearish
Amazon Shares Slip as FTC Lawsuit Looms

Shares of Amazon dropped about 3% in afternoon trading and were recently on pace for their largest percent decrease since July 23, when they fell 4.6%. The Wall Street Journal reported today that the Federal Trade Commission plans to file a lawsuit against the e-commerce giant, alleging it manipulated prices to deceive advertisers into paying higher prices to promote their products.

Amazon stock falls as FTC prepares ad-pricing lawsuit
InvestorsHub25d agobearish
Amazon stock falls as FTC prepares ad-pricing lawsuit

Key takeawaysThe FTC and more than 20 state attorneys general reportedly plan to sue Amazon over its advertising-auction practices. Regulators are expected to allege that undisclosed price floors increased advertisers’ costs and generated tens of billions of dollars for Amazon.

Chipotle (CMG) Debuts Pollo Asado And Chili Lime Chips
Simply Wall St.25d agoneutral
Chipotle (CMG) Debuts Pollo Asado And Chili Lime Chips

Chipotle Mexican Grill (NYSE:CMG) introduced an updated Pollo Asado recipe and new Chili Lime Chips as limited time menu items. The Chili Lime Chips are based on a viral fan trend, reflecting how the company is reacting to social media driven ordering habits. This is the first time Chipotle has launched two limited time offerings at the same time, signaling a shift in its menu rollout approach. For readers who want to explore other under the radar quality stocks in a similar consumer...

Protagonist Wins FDA Approval for MIMRYLO in Rare Blood Cancer Treatment
MarketBeat25d agobullish
Protagonist Wins FDA Approval for MIMRYLO in Rare Blood Cancer Treatment

Protagonist Therapeutics (NASDAQ:PTGX) said the U.S. Food and Drug Administration has approved rusfertide, to be marketed as MIMRYLO, for the treatment of erythrocytosis in adults with polycythemia vera, or PV. The approval marks the company’s second FDA-approved medicine this year, following the M